A Phase II, Open-Label, Single Arm Trial to Assess the Efficacy and Safety of the Combination of Tisagenlecleucel and Ibrutinib in Mantle Cell Lymphoma (TARMAC)

被引：4
|
作者：
Minson, Adrian
Hamad, Nada
Butler, Jason P.
Westerman, David Alan
Ritchie, David
Blombery, Piers
Seymour, John F.
Tam, Constantine S.
Dickinson, Michael
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-138946
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial
    Younes, Anas
    Oki, Yasuhiro
    Bociek, R. Gregory
    Kuruvilla, John
    Fanale, Michelle
    Neelapu, Sattva
    Copeland, Amanda
    Buglio, Daniela
    Galal, Ahmed
    Besterman, Jeffrey
    Li, Zuomei
    Drouin, Michel
    Patterson, Tracy
    Ward, M. Renee
    Paulus, Jessica K.
    Ji, Yuan
    Medeiros, L. Jeffrey
    Martell, Robert E.
    LANCET ONCOLOGY, 2011, 12 (13): : 1222 - 1228
  • [42] Regorafenib-avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial
    Cousin, Sophie
    Cantarel, Coralie
    Guegan, Jean-Philippe
    Mazard, Thibault
    Gomez-Roca, Carlos
    Metges, Jean-Philippe
    Bellera, Carine
    Adenis, Antoine
    Korakis, Iphigenie
    Poureau, Pierre-Guillaume
    Bourcier, Kevin
    Toulmonde, Maud
    Kind, Michele
    Rey, Christophe
    Auzanneau, Celine
    Bessede, Alban
    Soubeyran, Isabelle
    Italiano, Antoine
    EUROPEAN JOURNAL OF CANCER, 2022, 162 : 161 - 169
  • [43] A SINGLE-ARM, OPEN-LABEL, PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF ABEMACICLIB IN PATIENTS WITH RECURRENT OLIGODENDROGLIOMA: TRIALS IN PROGRESS
    Bagley, Stephen
    Nasrallah, MacLean
    O'Rourke, Donald
    Hussain, Jasmin
    Maloney-Wilensky, Eileen
    Prior, Timothy
    Brem, Steven
    Desai, Arati
    NEURO-ONCOLOGY, 2019, 21 : 219 - 219
  • [44] Combination of Ibrutinib With Rituximab in Previously Untreated Older Patients With Mantle Cell Lymphoma-A Phase II Clinical Trial
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (04) : 8 - 8
  • [45] Efficacy and Safety of Ibrutinib in Combination With Rituximab as Frontline Treatment for Indolent Clinical Forms of Mantle Cell Lymphoma: Preliminary Results of the Geltamo IMCL-2015 Phase II Trial
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (02) : 22 - 22
  • [46] A single arm, open-label multicenter phase II trial of everolimus in patients with relapsed/refractory germ cell cancer(RADIT)
    Fenner, Martin H.
    Dieing, Annetta
    Oechsle, Karin
    Hentrich, Marcus
    Gauler, Thomas Christoph
    Lorch, Anja
    Kopp, Hans-Georg
    Beyer, Joerg
    Bokemeyer, Carsten
    Gruenwald, Viktor
    Honecker, Friedmann
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] A single arm, open-label, phase II study to assess the efficacy of locitanib in patients with FGFR1-amplified surmounts NSCLC (sqNSCLC)
    Spigel, David R.
    Cereda, Roberta
    Litten, Jason B.
    Allen, Andrew R.
    Glaccone, Giuseppe
    Socinski, Mark A.
    Camidge, D. Ross
    Besse, Benjamin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] A multicenter, open-label, early access treatment protocol for ibrutinib in patients with relapsed or refractory mantle cell lymphoma
    Martin, Peter
    Goy, Andre
    Ramchandren, Radhakrishnan
    Ferrante, Lucille
    Londhe, Anil
    McGowan, Tracy
    Bartlett, Nancy L.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (04) : 1027 - 1030
  • [49] Efficacy and safety of venetoclax in combination with cytarabine and azacitidine (VAA) in relapsed/refractory acute myeloid leukemia: An open-label, single-arm, phase II study.
    You, Liangshun
    Liu, Yi
    Mai, Wenyuan
    Zhou, De
    Xie, Wanzhuo
    Mao, Liping
    Zhou, Xinping
    Tong, Hongyan
    Jin, Jie
    Meng, Haitao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma
    Izutsu, Koji
    Makita, Shinichi
    Nosaka, Kisato
    Yoshimitsu, Makoto
    Utsunomiya, Atae
    Kusumoto, Shigeru
    Morishima, Satoko
    Tsukasaki, Kunihiro
    Kawamata, Toyotaka
    Ono, Takaaki
    Rai, Shinya
    Katsuya, Hiroo
    Ishikawa, Jun
    Yamada, Hironori
    Kato, Kazunobu
    Tachibana, Masaya
    Kakurai, Yasuyuki
    Adachi, Nobuaki
    Tobinai, Kensei
    Yonekura, Kentaro
    Ishitsuka, Kenji
    BLOOD, 2023, 141 (10) : 1159 - 1168
12345